Real-world study of isavuconazole adverse events based on pharmacovigilance spontaneous reporting systems

Isavuconazole has fewer interactions and less liver, kidney and cardiac toxicity than other triazole antibiotics. The identification of novel AEs necessitates meticulous attention and further investigation and analysis.